Ventures

Built in KSA

ClotCode

Genetic screening for clotting disorders, run in the Kingdom rather than sent abroad.


Sector
Genomic diagnostics
Stage
Pre-seed · incubated
Headquarters
Saudi Arabia

The problem

Clotting disorders surface as deep vein thrombosis, pulmonary embolism, heart attack, stroke and pregnancy loss. Much of the genetic testing for them is provided from abroad.

The product

The Thrombophilia Gene Panel: a genetic test kit that targets five mutations, built to be low-cost and rapid.

Proof

  • A gene panel targeting five mutations behind early clotting disorders.
  • Developed by a genetics research team at Imam Abdulrahman Bin Faisal University.

People

  • Dr. Huseyin TombulogluAssociate Professor, Department of Genetics Research
  • Reham AltwayanMS in Biotechnology

Built with

  • Imam Abdulrahman Bin Faisal UniversityDepartment of Genetics Research, the team's home institution